Tower Research Capital (TRC)’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14K | Buy |
402
+347
| +631% | +$2.71K | ﹤0.01% | 4545 |
|
|
2025
Q1 | $756 | Buy |
55
+22
| +67% | +$302 | ﹤0.01% | 4835 |
|
|
2024
Q4 | $3.12K | Buy |
33
+26
| +371% | +$2.46K | ﹤0.01% | 4711 |
|
|
2024
Q3 | $3.7K | Sell |
7
-2
| -22% | -$1.06K | ﹤0.01% | 4793 |
|
|
2024
Q2 | $7.91K | Buy |
9
+4
| +80% | +$3.52K | ﹤0.01% | 4410 |
|
|
2024
Q1 | $3.37K | Buy |
+5
| New | +$3.37K | ﹤0.01% | 4874 |
|
|
2023
Q4 | – | Hold |
0
| – | -$2.69K | – | 5478 |
|
|
2023
Q3 | – | Hold |
0
| – | -$11.7K | – | 5119 |
|
|
2023
Q2 | – | Hold |
0
| – | -$2K | – | 3914 |
|
|
2023
Q1 | – | Hold |
0
| – | -$4K | – | 5392 |
|
|
2022
Q4 | – | Hold |
0
| – | -$6K | – | 5054 |
|
|
2022
Q3 | – | Hold |
0
| – | -$8K | – | 5041 |
|
|
2022
Q2 | – | Hold |
0
| – | -$6K | – | 4701 |
|
|
2022
Q1 | – | Hold |
0
| – | -$6K | – | 4919 |
|
|
2021
Q4 | – | Hold |
0
| – | -$4K | – | 5061 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4995 |
|